ChromaDex
CDXC
$3.30
Share price
-5.17%
Change (1 day)
112.90%
Change (1 year)
Categories
ChromaDex (CDXC) - Net assets
Net assets on the balance sheet as of December 2023 : $28.45 M
According to ChromaDex's latest financial reports the company has $28.45 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ChromaDex - Net assets on balance sheet (from 2007 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $28.45 M | -0.75% |
| 2022-12-31 | $28.67 M | -9.63% |
| 2021-12-31 | $31.72 M | 93.17% |
| 2020-12-31 | $16.42 M | -19.67% |
| 2019-12-31 | $20.44 M | -24.77% |
| 2018-12-31 | $27.17 M | -49.52% |
| 2017-12-31 | $53.83 M | 439.72% |
| 2016-12-31 | $9.97 M | 89.1% |
| 2015-12-31 | $5.27 M | 31.92% |
| 2014-12-31 | $3.99 M | -29.43% |
| 2013-12-31 | $5.66 M | 41.87% |
| 2012-12-31 | $3.99 M | 55.91% |
| 2011-12-31 | $2.56 M | -48.11% |
| 2010-12-31 | $4.93 M | 371.26% |
| 2009-12-31 | $1.04 M | -40.12% |
| 2008-12-31 | $1.74 M | |
| 2007-11-30 | $0 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sangamo Therapeutics
SGMO | $82.88 M | 191.28% | 🇺🇸 USA |
 Exelixis EXEL | $2.12 B | 7,378.25% | 🇺🇸 USA |